SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-058334
Filing Date
2020-11-13
Accepted
2020-11-13 17:13:39
Documents
1
Period of Report
2020-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7344
  Complete submission text file 0001209191-20-058334.txt   8733
Mailing Address C/O BLUEBIRD BIO, INC. 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Schenkein David P (Reporting) CIK: 0001578200 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 201312524

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Issuer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)